Flow distribution and cross filtration in hollow fiber hemodialyzers.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Alessandra Brendolan.
Explore the source record for details and available documents.
BACKGROUND/AIMS: The dialysis outcome is strongly affected by the function of the vascular access. It has been suggested that access clotting may be related to increased hematocrit (Hct) or excessive ultrafiltration during dialysis. The present study was designed to evaluate the changes of vascular access flow during hemodialysis in 18 end-stage renal disease patients with native arteriovenous fistulas and the possible correlations with Hct and mean arterial pressure (MAP). METHODS: We utilized a noninvasive vascular access flow measurement technique, based on a transcutaneous optical sensor, to evaluate the flow in the access before and after a single hemodialysis session. At the beginning and at the end of the session, the blood flow was measured noninvasively, placing the sensor approximately 2 in from the point of insertion of the arterial needle. At the same time, Hct and MAP were measured directly. All patients were on hemodialysis for more than 3 months. RESULTS: There was a significant increase in Hct, likely due to ultrafiltration and consequent hemoconcentration, from the beginning to the end of the dialysis session. In detail, the Hct increased from 32.6 +/- 1.9 to 35.4 +/- 1.8% (p < 0.001), while the MAP did not present significant variations. The blood flow did not show significant variations, increasing from 780 +/- 312 to 919 +/- 411 ml/min after the session. Because of the stability of the MAP, we could dissociate the effects of the Hct from those of the MAP on blood flow variations. CONCLUSION: Our study suggests that the blood flow in native fistulas is not affected by the acute rise in Hct due to ultrafiltration during hemodialysis. The transcutaneous access flow measurement technique appears to be reliable and accurate, and it could represent an important diagnostic tool.
Explore the source record for details and available documents.
The efficiency of a hemodialyzer is largely dependent on its ability to facilitate diffusion between blood and dialysis solution. The diffusion process can be impaired if there is a mismatch between blood and dialysate flow distribution in the dialyzer. This article describes the distribution of the blood and dialysate flows in hollow-fiber hemodialyzers analyzed with a computerized scanning technique. Blood flow distribution was studied in vitro by dye injection in the blood compartment during experimental extracorporeal circulation using human blood with hematocrit (Hct) adjusted at 25 and 40%. Sequential images were obtained with a helical scanner in a 1-cm-thick fixed longitudinal section of the dialyzer. Average and regional blood flow velocity and wall shear rates were measured by using the reconstructed imaging sequence. The method allowed the calculation of single-fiber blood flow and single-fiber wall shear rate (SF wSh) in different regions of the hemodialyzer. In 38 patients on chronic hemodialysis, creatinine and phosphate clearance displayed a significantly negative correlation with Hct (P < 0.05), but this correlation was not found for urea, although a trend toward reduction could be observed. The suggested explanation of this phenomenon is the significant reduction in effective plasma water flow across the hemodialyzer in presence of a progressive rise in Hct. The second explanation for this phenomenon may be found in the nonhomogeneous distribution of blood flow within the fibers observed at the sequential imaging. This, in fact, could also explain the negative trend observed for urea. At higher Hct levels, single-fiber blood flow velocity and SF wSh were significantly lower in the fibers situated at the periphery of the bundle. At the same time, SF wSh tended to decrease in peripheral fibers, showing a value near half of that observed in the central fibers of the bundle (165 versus 301 s(-1)). A similar technique was used to study the flow distribution in the dialysate compartment in three different types of hemodialyzers with characteristic dialysate compartment design: (A) standard configuration; (B) space yarns (spacing filaments preventing contact between fibers); and (C) Moiré structure (wave-shaped fibers to prevent contact between adjacent fibers). Clinical sessions of hemodialysis were also carried out to measure blood- and dialysate-side urea clearances in the different hemodialyzers. Macroscopic and densitometric analysis revealed that flow distribution was most homogeneous in the dialyzer with Moiré structure (type C) and least homogeneous in the standard dialyzer (type A). Space yarns (type B) gave an intermediate dialysate flow distribution. Urea clearance (P < 0.001) increased significantly with types B and C, compared with the standard dialyzer. Type C had the highest clearances, although they were not significantly greater than type B. In conclusion, a significant blood-to-dialysate flow mismatch may occur in hollow-fiber hemodialyzers due to either uneven blood flow distribution or a dialysate channeling phenomenon external to the fiber bundle. Improvement in dialyzer design may overcome these problems, at least in part.
Mortality rates in septic shock remain unacceptably high despite advances in our understanding of the syndrome and its treatment. Humoral factors are increasingly recognized to participate in the pathogenesis of septic shock, giving a biological rationale to therapies that might remove varied and potentially dangerous humoral mediators. While plasma water exchange in the form of hemofiltration can remove circulating cytokines in septic patients, the procedure, as routinely performed, does not have a substantial impact on their plasma levels. More intensive plasma water exchange, as high-volume hemofiltration (HVHF)can reduce levels of these mediators and potentially improve clinical outcomes. However, there are concerns about the feasibility and costs of HVHF as a continuous modality--very high volumes are difficult to maintain over 24 hours and solute kinetics are not optimized by this regimen. We propose pulse HVHF (PHVHF)-HVHF of 85 ml/kg/hr for 6-8 hours followed by continuous venovenous hemofiltration (CVVH) of 35 ml/kg/hr for 16-18 hours-as a new method to combine the advantages of HVHFimprove solute kinetics, and minimize logistic problems. We treated 15 critically ill patients with severe sepsis and septic shock using daily PHVHF in order to evaluate the feasibility of the technique, its effects on hemodynamics, and the impact of the treatment on pathologic apoptosis in sepsis. Hemodynamic improvements were obtained after 6 hours of PHVHF and were maintained subsequently by standard CVVHas demonstrated by the reduction in norepinephrine dose. PHVHFbut not CVVHsignificantly reduces apoptotic plasma activity within 1 hour and the pattern was maintained in the following hours. PHVHF appears to be a feasible modality that may provide the same or greater benefits as HVHFwhile reducing the workload and cost.
Explore the source record for details and available documents.